prostate header graphic
Prostate Problem Guide

Advanced Prostate Cancer - Options For Treatment

Prostate cancer normally develops within the peripheral area of the prostate gland and this initially small area of cancerous tissue cannot be felt on a digital rectal examination (DRE) but is often picked up through a PSA test or an ultrasound examination. At this point prostate cancer is described as being in Stage I or is described as a T1 cancer.

As the cancerous region grows within the prostate it will create abnormalities which can now be felt during a DRE and, at this point, the disease is said to have progressed to Stage II or become a T2 cancer.

In both Stage I and Stage II cancer is confined to the prostate gland and is normally treated surgically, with radiation therapy, with cryosurgery or using ultrasound.

As the cancer continues to grow it will spread into surrounding tissues within the pelvic area and will move into Stage III or be classed as a T3 cancer. Finally, prostate cancer cells will be carried to regions of the body outside of the pelvic area and prostate cancer reaches Stage IV or becomes a T4 cancer. It is these two stages of the disease that are classed as being "advanced prostate cancer".

The treatment of advanced prostate cancer is aimed principally at slowing the spread of the disease, providing the best possible quality of life for the patient and extending the patient's life as far as is possible. Although it is possible to cure prostate cancer, particularly in Stage III, the advanced nature of the disease makes this a difficult task and the reality of the situation is that treatment at this point generally represents management of the disease rather than a cure for it.

As prostate cancer cells require male hormones (such as testosterone) to grow, the main form of treatment for advanced prostate cancer is hormone treatment to reduce the production of testosterone.

Hormone therapy may include the use of drugs to reduce testosterone levels in the body or to block the action of testosterone and other male hormones. Treatment options will also include the removal of the testicles (orchiectomy) which produce 95% of the testosterone found in the body.

In some cases of Stage IV cancer hormone therapy may not be effective, or may have only limited results, and patients may require systematic radiation therapy or chemotherapy.

Further information on advanced prostate cancer treatment:

FDA approves new drug for advanced prostate cancer - FDA.gov


Medscape

FDA approves new drug for advanced prostate cancer
FDA.gov
The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men ...
Bayer Gets FDA Approval for Advanced Prostate Cancer DrugWall Street Journal
New drug approved for advance prostate cancerNBCNews.com
New Drug Approved for Advanced Prostate CancerWebMD
Oncology Nurse Advisor -Nature World News -Medscape
all 51 news articles »

Secondary Hormone Therapy for Castration-Resistant Prostate Cancer - Cancer Network


Secondary Hormone Therapy for Castration-Resistant Prostate Cancer
Cancer Network
The majority of patients with systemic prostate cancer treated with androgen deprivation therapy (ADT) will develop castration-resistant prostate cancer (CRPC). CRPC is defined by prostate-specific antigen (PSA) or radiographic progression in the ...

and more »

Penn Medicine Reveals New Potential Therapy for Advanced Cancers - Penn: Office of University Communications


Penn Medicine Reveals New Potential Therapy for Advanced Cancers
Penn: Office of University Communications
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate ...

and more »